Antibody molecules having binding specificity for human IL-13

Details for Australian Patent Application No. 2010222693 (hide)

Owner UCB Pharma S.A.

Inventors Gozzard, Neil; Lawson, Alastair David Griffiths; Lightwood, Daniel John; Palframan, Roger Thomas; Smith, Bryan John; Tyson, Kerry Louise

Agent Watermark

Pub. Number AU-A-2010222693

PCT Pub. Number WO2010/103274

Priority 0904214.4 11.03.09 GB

Filing date 10 March 2010

Wipo publication date 16 September 2010

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

29 September 2011 PCT application entered the National Phase

  PCT publication WO2010/103274 Priority application(s): WO2010/103274

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010222694-Fluid injection

2010222692-Essential fatty acid compounds